An Act To Establish an Exemption to the 30-day Supply Limitation on Certain Pain Medication
Maine Legislature, Session 128, LD 0232
Committee: Health and Human Services
Sponsors: DAVIS, BLACK, CYRWAY, HAMPER, MIRAMANT, TIMBERLAKE
Amends: 32 MRSA §2210, 32 MRSA §2600-C, 32 MRSA §3300-F, 32 MRSA §3657, 32 MRSA §18308

Legislative Document
No. 232
S.P. 78
In Senate, January 24, 2017
An Act To Establish an Exemption to the 30-day Supply Limitation 
on Certain Pain Medication
Reference to the Committee on Health and Human Services suggested and ordered printed.
HEATHER J.R. PRIEST
Secretary of the Senate
Presented by Senator DAVIS of Piscataquis.
Cosponsored by Representative BLACK of Wilton and
Senators: CYRWAY of Kennebec, HAMPER of Oxford, MIRAMANT of Knox, 
Representative: TIMBERLAKE of Turner.
Be it enacted by the People of the State of Maine as follows: 
Sec. 1.  32 MRSA §2210, sub-§1, ¶C, as enacted by PL 2015, c. 488, §13, is 
amended to read: 
C.  On or after January 1, 2017, within a 30-day period, more than a 30-day supply of 
an opioid medication to a patient under treatment for chronic pain or more than a 
6-month supply of an opioid medication to a patient under treatment for chronic pain 
who will be out of the country at the end of the 30-day period.  "Chronic pain" has 
the same meaning as in Title 22, section 7246, subsection 1-C; or 
Sec. 2.  32 MRSA §2600-C, sub-§1, ¶C, as enacted by PL 2015, c. 488, §17, is 
amended to read: 
C.  On or after January 1, 2017, within a 30-day period, more than a 30-day supply of 
an opioid medication to a patient under treatment for chronic pain or more than a 
6-month supply of an opioid medication to a patient under treatment for chronic pain 
who will be out of the country at the end of the 30-day period.  For purposes of this 
paragraph, "chronic pain" has the same meaning as in Title 22, section 7246, 
subsection 1-C; or 
Sec. 3.  32 MRSA §3300-F, sub-§1, ¶C, as enacted by PL 2015, c. 488, §20, is 
amended to read: 
C.  On or after January 1, 2017, within a 30-day period, more than a 30-day supply of 
an opioid medication to a patient under treatment for chronic pain or more than a 
6-month supply of an opioid medication to a patient under treatment for chronic pain 
who will be out of the country at the end of the 30-day period.  "Chronic pain" has 
the same meaning as in Title 22, section 7246, subsection 1-C; or 
Sec. 4.  32 MRSA §3657, sub-§1, ¶C, as enacted by PL 2015, c. 488, §23, is 
amended to read: 
C.  On or after January 1, 2017, within a 30-day period, more than a 30-day supply of 
an opioid medication to a patient under treatment for chronic pain or more than a 
6-month supply of an opioid medication to a patient under treatment for chronic pain 
who will be out of the country at the end of the 30-day period.  "Chronic pain" has 
the same meaning as in Title 22, section 7246, subsection 1-C; or 
Sec. 5.  32 MRSA §18308, sub-§1, ¶C, as enacted by PL 2015, c. 488, §32, is 
amended to read: 
C.  On or after January 1, 2017, within a 30-day period, more than a 30-day supply of 
an opioid medication to a patient under treatment for chronic pain or more than a 
6-month supply of an opioid medication to a patient under treatment for chronic pain 
who will be out of the country at the end of the 30-day period.  For purposes of this 
paragraph, "chronic pain" has the same meaning as in Title 22, section 7246, 
subsection 1-C; or 
SUMMARY 
Current law prohibits an individual licensed to prescribe opioid medication from 
prescribing more than a 30-day supply of an opioid medication to a patient under 
treatment for chronic pain.  This bill allows an individual licensed to prescribe opioid 
medication to prescribe no more than a 6-month supply of an opioid medication to a 
patient under treatment for chronic pain who will be out of the country at the end of the 
30-day period.